reports
Danaher Corp: 1 director
A director at Danaher Corp sold 9,005 shares at 265.000USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Teleflex Publishes 2023 Global Impact Report
Teleflex Publishes 2023 Global Impact Report Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program WAYNE, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2023 Global Impact Report. The report outlines recent accomplishments and sets new targets to support the company’s Corporate Social Responsibility (CSR) program and aligns with the Global Reporting Initiative (GRI), the Sustainability Accounting Standards Board (SASB), and Taskforce on Climat...
Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow...
Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug Administration WAYNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies and pioneer in intraosseous vascular access, today announced the launch of the Arrow™ EZ-IO™ Intraosseous Access Procedure Tray. This sterile, single-use tray includes all the components required for the IO access procedure, enabling a streamlined clinician workf...
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involv...
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association Annual Meeting in San Antonio, TX, May 3 – 6, 2024, showcasing excellent patient experience* with the Prostatic Urethral Lift (PUL) with the UroLift™...
Teleflex Announces Quarterly Dividend
Teleflex Announces Quarterly Dividend WAYNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 14, 2024, to shareholders of record at the close of business on May 15, 2024. Additional information about Teleflex can be obtained from the company’s website at . About Teleflex Incorporated Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We ...
Amphenol Announces Second Quarter 2024 Dividend
WALLINGFORD, Conn.--(BUSINESS WIRE)-- Amphenol Corporation (NYSE: APH) announced today that its Board of Directors approved the second quarter 2024 dividend on its Common Stock in the amount of $0.22 per share at its meeting held on May 1, 2024. The Company will pay this second quarter 2024 dividend on July 10, 2024 to shareholders of record as of June 18, 2024. About Amphenol Amphenol Corporation is one of the world’s largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and...
Teleflex Reports First Quarter Financial Results and Full Year 2024 Ou...
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook WAYNE, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. First quarter financial summary Revenues of $737.8 million, up 3.8% compared to the prior year period; up 3.8% on a constant currency basisGAAP diluted EPS from continuing operations of $0.33, compared to $1.63 in the prior year periodAdjusted diluted EPS from continuing operations of $3.21, compared to $3.09 in the prior year period 2...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies t...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine post-surgery medication use, rates of hospitalization and adverse events of standard BPH treatments -Teleflex unveils latest advancements in BPH treatment with UroLift™ 2 System with Advanced Tissue Control (ATC) designed to treat all prostate types -...
Teleflex Announces the Limited Market Release of the Wattson™ Temporar...
Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire Company expands structural heart portfolio and begins the limited market release of a bipolar temporary pacing guidewire intended to introduce and position catheters and other interventional devices within the chambers of the heart while transmitting an electrical signal from an external pulse generator to the heart WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the Wattson™ Temporary Pacing Gui...
Teleflex to Present at the BofA Securities 2024 Health Care Conference
Teleflex to Present at the BofA Securities 2024 Health Care Conference WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 14, 2024, at 2:20 p.m. (PT). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at . About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and ...
Amphenol Reports First Quarter 2024 Results and Announces New Stock Re...
WALLINGFORD, Conn.--(BUSINESS WIRE)-- Amphenol Corporation (NYSE: APH) today reported first quarter 2024 results. In addition, the Company is announcing a new three-year, $2 billion stock repurchase program. “We are pleased to have closed the first quarter of 2024 with sales and Adjusted Diluted EPS both exceeding the high end of our guidance,” said Amphenol President and Chief Executive Officer, R. Adam Norwitt. “Sales increased from prior year by 9%, driven by growth in the IT datacom, commercial air, automotive and defense markets as well as contributions from the Company’s acquisition pr...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Shifting Exposure From Growth to Value Note: This is an abbreviated report (no detailed Sector comments or Russell grids). We will return to our normal report structure next week. While the market remains in consolidation/pullback mode and we are not out of the woods, it is possible that further downside is limited from here on the S&P 500. Since late-February, we have discussed important gap support from 2/22/24 at 4983-5050 on the S&P 500, and that as long as the S&P 500 is above 4983 that b...
C CITIGROUP INC.
SO SOUTHERN COMPANY
PH PARKER-HANNIFIN CORPORATION
NEE NEXTERA ENERGY INC.
CMC JPMORGAN CHASE & CO.
GS GOLDMAN SACHS GROUP INC.
FLS FLOWSERVE CORPORATION
ETR ENTERGY CORPORATION
ETN EATON CORP. PLC
DUK DUKE ENERGY CORPORATION
BMI BADGER METER INC.
AEP AMERICAN ELECTRIC POWER COMPANY INC.
XYL XYLEM INC.
ITT ITT INC.
SCHW CHARLES SCHWAB CORPORATION
IR INGERSOLL RAND INC.
TT TRANE TECHNOLOGIES PLC
Amphenol Corporation Releases 2023 Sustainability Report
WALLINGFORD, Conn.--(BUSINESS WIRE)-- Amphenol Corporation (NYSE: APH) today released its 2023 Sustainability Report. “Amphenol continues to make a positive impact on the environment, the communities in which we operate and our global team members, all while delivering exceptional performance for our shareholders,” said Amphenol President and Chief Executive Officer, R. Adam Norwitt. “During 2023, we continued to make meaningful advances in energy management through our increased use of renewable energy sources and the acquisition of renewable energy certificates. We also made improvements...
Teleflex Announces First Quarter 2024 Earnings Conference Call Informa...
Teleflex Announces First Quarter 2024 Earnings Conference Call Information WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024. To participate in the conference call, please utilize this to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, . An audio replay of the call will be available beginning at 11:00 am Easte...
Amphenol Corporation Announces Pricing of Senior Notes Offering
WALLINGFORD, Conn.--(BUSINESS WIRE)-- Amphenol Corporation (NYSE: APH) announced today the pricing of its offering of $450 million aggregate principal amount of senior notes due 2027 (the “2027 Notes”), $450 million aggregate principal amount of senior notes due 2029 (the “2029 Notes”) and $600 million aggregate principal amount of senior notes due 2034 (the “2034 Notes”, and together with the 2027 Notes and 2029 Notes, the “Notes”). The 2027 Notes will have an interest rate of 5.050% per annum, the 2029 Notes will have an interest rate of 5.050% per annum, and the 2034 Notes will have an inte...
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced T...
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced Tissue Control (ATC) feature on its unified UroLift™ 2 System platform designed for the treatment of benign prostatic hyperplasia (BPH) symptoms in men with all prostate types up to 100g. The UroLift™ 2 System with Advanced Tissue Control (UroLift™ 2 ATC) has rece...
Teleflex’s Climate Targets Validated by the Science Based Targets Init...
Teleflex’s Climate Targets Validated by the Science Based Targets Initiative Teleflex commits to reach net-zero greenhouse gas emissions across its value chain by 2050. WAYNE, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced its near- and long-term climate change targets have been validated by the Science Based Targets initiative (SBTi). The announcement comes ahead of the company’s release of its 2023 Global Impact Report, which will be published in May 2024. Teleflex has responded to the SBTi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.